Core Scientific, Inc./tx (CORZZ) stock
CORZZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$12.85−1.46 (-10.20%)
Close on Oct 30, 2026Market cap $4.13BP/E –Yield –
Core Scientific shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Core Scientific's shares outstanding was 325M at Jun 30, 2026. For fiscal 2025 it was 318M, up 24.3% from the year before. The highest annual figure on record is 380M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 318M | +24.3% |
| FY2024 | Dec 31, 2024 | 256M | -32.7% |
| FY2023 | Dec 31, 2023 | 380M | +11.5% |
| FY2022 | Dec 31, 2022 | 341M | +46.0% |
| FY2021 | Dec 31, 2021 | 233M | +48.0% |
| FY2020 | Dec 31, 2020 | 158M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 325M | +2.3% |
| Q1 FY2026 | Mar 31, 2026 | 323M | -11.1% |
| Q4 FY2025 | Dec 31, 2025 | 320M | +21.2% |
| Q3 FY2025 | Sep 30, 2025 | 319M | +8.9% |
| Q2 FY2025 | Jun 30, 2025 | 318M | +78.1% |
| Q1 FY2025 | Mar 31, 2025 | 363M | +28.6% |
| Q4 FY2024 | Dec 31, 2024 | 264M | -31.4% |
| Q3 FY2024 | Sep 30, 2024 | 292M | -23.5% |
| Q2 FY2024 | Jun 30, 2024 | 179M | -52.5% |
| Q1 FY2024 | Mar 31, 2024 | 283M | -24.7% |
| Q4 FY2023 | Dec 31, 2023 | 385M | -5.6% |
| Q3 FY2023 | Sep 30, 2023 | 382M | +8.0% |
| Q2 FY2023 | Jun 30, 2023 | 376M | +15.6% |
| Q1 FY2023 | Mar 31, 2023 | 375M | +22.1% |
| Q4 FY2022 | Dec 31, 2022 | 408M | +7.7% |
| Q3 FY2022 | Sep 30, 2022 | 354M | +49.5% |
| Q2 FY2022 | Jun 30, 2022 | 325M | +104.5% |
| Q1 FY2022 | Mar 31, 2022 | 307M | +74.7% |
| Q4 FY2021 | Dec 31, 2021 | 379M | – |
| Q3 FY2021 | Sep 30, 2021 | 237M | – |
| Q2 FY2021 | Jun 30, 2021 | 159M | – |
| Q1 FY2021 | Mar 31, 2021 | 176M | – |